Mentha piperita (Peppermint)–Derived Ingredients: CIR Safety Assessment Summary
CIR safety assessment summary for Mentha piperita (Peppermint)–Derived Ingredients: ingredients reviewed, panel verdict, use concentration context, condit.
Mentha piperita (Peppermint)–Derived Ingredients appears in a CIR safety assessment covering Mentha piperita (Peppermint)–Derived Ingredients. The panel verdict for the report is insufficient data. The Expert Panel for Cosmetic Ingredient Safety concluded that the following 7 M piperita (peppermint)–derived ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-sensitizing: · M Piperita (Peppermint) Oil · M Piperita (Peppermint) Extract · M Piperita (Peppermint) Leaf · M Piperita (Peppermint) Leaf Cell Extract* · M.
| Field | CIR value |
|---|---|
| Primary ingredient | Mentha piperita (Peppermint)–Derived Ingredients |
| CIR verdict | insufficient data |
| Report type | Safety Assessment |
| Date | Toxicology 2023 |
| CAS numbers | 8006-90-4, 84082-70-2 |
| Use concentration context | present practices of use and concentration described in the safety assessment |
| Conditions or carve-outs |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Mentha piperita (Peppermint)–Derived Ingredients.
Safety Conclusion
The conclusion for Mentha piperita (Peppermint)–Derived Ingredients should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
For use levels, the report gives this concentration context: present practices of use and concentration described in the safety assessment. That language is the safe-use context shown for this page.
Conditions
The Expert Panel for Cosmetic Ingredient Safety concluded that the following 7 M piperita (peppermint)–derived ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-sensitizing: · M Piperita (Peppermint) Oil · M Piperita (Peppermint) Extract · M Piperita (Peppermint) Leaf · M Piperita (Peppermint) Leaf Cell Extract* · M.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Mentha piperita (Peppermint)–Derived Ingredients, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Mentha piperita (Peppermint)–Derived Ingredients should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Mentha piperita (Peppermint)–Derived Ingredients, with source details retained at the bottom for audit.
Source
- CIR report: Amended Safety Assessment of Mentha piperita (Peppermint)–Derived Ingredients as Used in Cosmetics Wilbur Johnson*, Wilma F. Bergfeld**, Donald V. Belsito**, Ronald A. Hill***, Curtis D. Klaassen**, Daniel C. Liebler***, James G. Marks***,
- CIR source file: PRS741.pdf
- Extraction JSON: CIR Safety Assessment Database
- Conclusion page in CIR extraction: 24